Stephen Dale, Chief Medical Officer at Kura Oncology, Inc. (KURA), sold 18,450 shares at $13.87 ($256K) on 2023-01-27, disclosed to the SEC on 2023-01-31.
Open-market sale of $256k KURA by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $13.87 | 4,840 | $67K | 26.2% |
| 2 | $13.87 | 4,840 | $67K | 26.2% |
| 3 | $13.89 | 4,385 | $61K | 23.8% |
| 4 | $13.89 | 4,385 | $61K | 23.8% |
| Total | $13.88 avg | 18,450 | $256K | 100% |